Premed · Premed · Immunology
Lecture 16: Helper T Cell Subsets: Th1, Th2, Th17, Treg
Immunology
Learning Objectives
By the end of this lecture, students will be able to:
- Describe the major CD4+ T helper cell subsets and their defining cytokines and transcription factors
- Explain the functional roles of Th1, Th2, Th17, Treg, and Tfh cells in immune responses
- Describe the cytokine signals that drive differentiation of each subset
- Explain the concept of T helper cell plasticity
- Discuss the clinical implications of dysregulated T helper cell responses
Lecture Content
I. Overview of CD4+ T Helper Cell Differentiation
Naive CD4+ T cells do not commit to a single effector program until they are activated in the periphery. Their differentiation into distinct functional subsets depends on the cytokine environment (Signal 3) provided by APCs and the surrounding microenvironment, the strength and duration of TCR signaling, and the co-stimulatory signals they receive. Each subset is defined by a master transcription factor that drives its differentiation, a signature cytokine profile that mediates its effects, and effector functions tailored to combat specific categories of pathogens. The major subsets are Th1, Th2, Th17, Treg, and Tfh, with additional subsets including Th9 and Th22.
II. Th1 Cells
Th1 differentiation is driven by IL-12 (produced by DCs and macrophages) and IFN-gamma (from NK cells and other T cells), which activate the master transcription factor T-bet (encoded by TBX21). T-bet also induces expression of the IL-12 receptor beta-2 subunit, creating a positive feedback loop that reinforces Th1 commitment. Th1 cells produce the signature cytokines IFN-gamma, TNF-alpha, lymphotoxin-alpha (LT-alpha), and IL-2.
Functionally, Th1 cells are the architects of cell-mediated immunity against intracellular pathogens. IFN-gamma drives classical macrophage activation (M1 polarization), enhancing intracellular killing through upregulated production of reactive oxygen species, nitric oxide, and lysosomal enzymes. Th1 responses also promote isotype switching to opsonizing antibody classes (IgG1 and IgG3 in humans) and activate CD8+ cytotoxic T lymphocytes. The pathogens best controlled by Th1 responses include Mycobacterium tuberculosis, Leishmania, Listeria, and various viruses. When dysregulated, Th1 responses contribute to organ-specific autoimmune diseases such as type 1 diabetes, multiple sclerosis, and rheumatoid arthritis, as well as delayed-type hypersensitivity (type IV) reactions. Importantly, IFN-gamma cross-regulates the immune response by inhibiting both Th2 and Th17 differentiation.
III. Th2 Cells
Th2 differentiation is initiated by IL-4, whose initial source may be basophils, mast cells, ILC2s, or NKT cells. The master transcription factor GATA-3 both promotes IL-4 production and inhibits IFN-gamma, establishing a positive feedback loop. Th2 cells produce IL-4, IL-5, IL-13, IL-9, and IL-25.
The effector functions of Th2 cells are directed toward extracellular parasites, particularly helminths. IL-4 drives B cell activation and isotype switching to IgE (and IgG4), while IL-5 recruits and activates eosinophils, the principal effector cells against helminth parasites. IL-13 induces mucus production and smooth muscle contraction in the airways and gut, promotes goblet cell hyperplasia, and contributes to alternative macrophage activation (M2 polarization) along with IL-4. IL-9 stimulates mast cell growth. When Th2 responses become misdirected against harmless environmental antigens, the result is allergic disease -- asthma, atopic dermatitis, allergic rhinitis, and food allergy. IL-4 cross-regulates by inhibiting Th1 differentiation, and IL-10 suppresses macrophage activation.
IV. Th17 Cells
Th17 cells differentiate under the combined influence of TGF-beta and IL-6, with IL-23 and IL-1-beta maintaining their pathogenicity. The master transcription factor is RORgamma-t (retinoic acid-related orphan receptor gamma t), and the signature cytokines include IL-17A, IL-17F, IL-22, IL-21, and GM-CSF.
Th17 cells specialize in recruiting neutrophils and strengthening epithelial barriers. IL-17 induces stromal and epithelial cells to produce G-CSF and CXCL8 (IL-8), driving neutrophil recruitment to sites of infection. IL-22 stimulates epithelial cells to produce antimicrobial peptides such as defensins and RegIII-gamma, reinforcing barrier integrity. These responses are critical for defense against extracellular bacteria (including Staphylococcus and Klebsiella) and fungi (particularly Candida). Dysregulated Th17 responses are implicated in numerous autoimmune and inflammatory conditions: psoriasis, inflammatory bowel disease, ankylosing spondylitis, and multiple sclerosis. This understanding has yielded effective therapies -- IL-17 inhibitors (secukinumab, ixekizumab) for psoriasis and ankylosing spondylitis, and IL-23 inhibitors (ustekinumab, guselkumab) for psoriasis and IBD. The clinical relevance of Th17 cells is further illustrated by Hyper-IgE syndrome (Job syndrome), in which STAT3 mutations impair Th17 differentiation, leading to chronic mucocutaneous candidiasis and recurrent staphylococcal infections.
V. Regulatory T Cells (Tregs)
Treg differentiation is driven by TGF-beta and IL-2, and notably, the absence of IL-6 favors Treg over Th17 commitment, highlighting the critical balance between these two fates. The master transcription factor FoxP3 is both necessary and sufficient for Treg identity and function. Mutations in FOXP3 cause IPEX syndrome (immune dysregulation, polyendocrinopathy, enteropathy, X-linked), a devastating condition characterized by severe multi-organ autoimmunity.
Two types of Tregs exist: thymic Tregs (tTregs or natural Tregs), generated during T cell development in the thymus and recognizing self-antigens, and peripheral Tregs (pTregs or induced Tregs), generated from naive CD4+ T cells in the periphery under the influence of TGF-beta, IL-2, and retinoic acid. Both share the phenotype CD4+CD25-high, FoxP3+, CTLA-4+, GITR+, and CD127-low.
Tregs suppress immune responses through multiple mechanisms. They secrete inhibitory cytokines (IL-10, TGF-beta, and IL-35), kill effector T cells and APCs through granzyme B/perforin-mediated cytolysis, disrupt effector T cell metabolism by consuming IL-2 through their high-affinity IL-2 receptor (CD25), suppress dendritic cell function through CTLA-4-mediated trans-endocytosis of B7 molecules, and produce adenosine via CD39/CD73, which suppresses surrounding effector cells. Clinically, Treg deficiency leads to autoimmunity (IPEX), while Treg expansion within tumors contributes to immune evasion. Treg-based therapy is being actively explored for autoimmune diseases and transplant tolerance.
<image>A four-quadrant diagram of the major CD4+ T helper subsets. Each quadrant contains: the subset name, the inducing cytokines (with source cell), the master transcription factor, the signature cytokines produced, the primary effector functions, the type of pathogen defended against, and the associated diseases when dysregulated. Quadrant 1 (top-left, red): Th1 -- IL-12/IFN-gamma, T-bet, IFN-gamma/TNF-alpha, macrophage activation, intracellular pathogens, autoimmunity. Quadrant 2 (top-right, blue): Th2 -- IL-4, GATA-3, IL-4/IL-5/IL-13, eosinophil/IgE, helminths, allergy. Quadrant 3 (bottom-left, orange): Th17 -- TGF-beta+IL-6/IL-23, RORgammat, IL-17/IL-22, neutrophil recruitment, extracellular bacteria/fungi, autoimmunity. Quadrant 4 (bottom-right, green): Treg -- TGF-beta+IL-2, FoxP3, IL-10/TGF-beta/IL-35, immune suppression, self-tolerance, IPEX if absent. Arrows between quadrants show cross-regulation: IFN-gamma inhibits Th2/Th17; IL-4 inhibits Th1/Th17; TGF-beta without IL-6 promotes Treg over Th17.</image>
VI. T Follicular Helper Cells (Tfh)
Tfh cells differentiate under the influence of IL-6, IL-21, and ICOS signaling, with Bcl-6 as their master transcription factor. They produce IL-21 and IL-4 and are located within the germinal centers of secondary lymphoid organs. Tfh cells provide essential help to B cells in germinal centers, promoting somatic hypermutation, affinity maturation, isotype switching, and the differentiation of plasma cells and memory B cells. Their key surface molecules include CXCR5 (which directs homing to B cell follicles), PD-1, ICOS, and CD40L. Excessive Tfh activity can drive autoantibody production, as seen in systemic lupus erythematosus, while insufficient Tfh function leads to impaired antibody responses.
VII. Additional T Helper Subsets
Beyond the major subsets, several additional helper populations have been described. Th9 cells, induced by TGF-beta and IL-4, produce IL-9 and participate in mast cell activation, anti-parasite immunity, and allergic inflammation. Th22 cells produce IL-22 without IL-17 and are important for skin immunity and wound healing. Tr1 (Type 1 regulatory) cells produce high levels of IL-10 but are FoxP3-negative, playing important roles in mucosal tolerance.
VIII. T Helper Cell Plasticity
T helper subsets are not terminally fixed fates. Under changing cytokine conditions, differentiated T helper cells can shift their phenotype, a property known as plasticity. Th17 cells can convert to a Th1-like phenotype in inflammatory conditions rich in IL-12. Tregs can acquire Th17 characteristics in the presence of IL-6. Th2 cells can partially shift toward a Th1 profile under strong IL-12 signaling. These transitions are mediated by epigenetic changes at cytokine and transcription factor loci and carry important clinical implications: therapeutic manipulation of the cytokine environment can potentially redirect immune responses from pathological to protective phenotypes.
<image>A diagram illustrating T helper cell plasticity and the cytokine network. In the center, a naive CD4+ T cell is shown. Arrows radiate outward to each T helper subset (Th1, Th2, Th17, Treg, Tfh), each driven by specific cytokine combinations. Bidirectional dotted arrows between subsets indicate plasticity: Th17 can convert to Th1 (IL-12-driven), Treg can convert to Th17 (IL-6-driven), Th2 can partially convert to Th1 (IL-12-driven). The balance between Th17 and Treg is highlighted as a critical axis: TGF-beta alone favors Treg, while TGF-beta + IL-6 favors Th17. This Th17/Treg balance is annotated as a key determinant of inflammation vs. tolerance.</image>
